|
|
Volumn 322, Issue 2-3, 1999, Pages 161-165
|
|
Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN E7;
CINNAMIC ACID DERIVATIVE;
CYCLINE;
DOXORUBICIN;
HEXAMETHYLENEBISACETAMIDE;
HISTONE DEACETYLASE;
HISTONE H4;
HYDROXAMIC ACID DERIVATIVE;
METHYLNITROSOUREA;
PROTEIN BCL 2;
PROTEIN P130;
TRANSCRIPTION FACTOR E2F;
TRICHOSTATIN A;
ACUTE GRANULOCYTIC LEUKEMIA;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL LINE;
CELL POLARITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG MEGADOSE;
GENE EXPRESSION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
HYBRID CELL;
MOUSE;
MYELODYSPLASTIC SYNDROME;
MYELOMA CELL;
NONHUMAN;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
THROMBOCYTOPENIA;
VIRUS CELL TRANSFORMATION;
WART VIRUS;
|
|
EID: 0033303876
PISSN: 07644469
EISSN: None
Source Type: Journal
DOI: 10.1016/S0764-4469(99)80039-0 Document Type: Article |
|
Times cited : (10)
|
|
References (23)
|
